Center for Drug Evaluation and Research

Results: 4314



#Item
41Pharmacology / Vaccines / Influenza vaccine / Center for Biologics Evaluation and Research / Influenza / Food and Drug Administration / Biologic / Adverse effect / Protein Sciences / Medicine / Health / Vaccination

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MDMarch 12, 2015 VIA FACSIMILE AND UPS (UNITED PARCEL SERVICE)

Add to Reading List

Source URL: www.fda.gov

Language: English
42Pharmacology / Pharmaceuticals policy / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Drug development / Drug Enforcement Administration / Medical cannabis / Office of Regulatory Affairs / Food and Drug Administration / Pharmaceutical sciences / Medicine

FDA Work on Medical Products Containing Marijuana Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs Center for Drug Evaluation and Review (CDER), Food and Drug Administration (FDA)

Add to Reading List

Source URL: www.fda.gov

Language: English
43Pharmaceutical sciences / Federal Food /  Drug /  and Cosmetic Act / Institutional review board / New Drug Application / Center for Biologics Evaluation and Research / Code of Federal Regulations / Food and Drug Administration / Medicine / Health

Federal Register / Vol. 76, NoMonday, April 4, Notices 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2013-05-23 10:28:52
44Pharmaceuticals policy / Pharmaceutical industry / Clinical research / Clinical pharmacology / Prescription Drug User Fee Act / Center for Drug Evaluation and Research / Generic drug / Drug development / Pharmaceutical sciences / Food and Drug Administration / Pharmacology

CDER Priorities Janet Woodcock M.D. Director, CDER, FDA CDER has Multiple Important Priorities • Diverse stakeholders: all have expectations that their

Add to Reading List

Source URL: www.fda.gov

Language: English
45Health / Pharmaceutical sciences / Pharmacology / Structured Product Labeling / Pharmaceutical industry / Biologic / Center for Biologics Evaluation and Research / Package insert / Food and Drug Administration / Medicine / Medical informatics

Our Submission Tracking Number (STN): BL

Add to Reading List

Source URL: www.fda.gov

Language: English
46Clinical research / Center for Biologics Evaluation and Research / Public Readiness and Emergency Preparedness Act / Center for Devices and Radiological Health / Influenza vaccine / Influenza / Medicine / Health / Food and Drug Administration

U.S. Department of Health & Human Services U.S. Food and Drug Administration FDA Facts: FDA’s Medical Countermeasures Initiative (MCMi)

Add to Reading List

Source URL: www.fda.gov

Language: English
47MedWatch / Health / Office of Regulatory Affairs / Center for Drug Evaluation and Research / Center for Veterinary Medicine / Adverse Event Reporting System / Adverse effect / Food and Drug Administration / Pharmaceutical sciences / Clinical research

FDAs MedWatch Program: Voluntarily Reporting Problems to the FDA

Add to Reading List

Source URL: www.fda.gov

Language: English
48Food and Drug Administration / Health / Pharmacy / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Adverse Event Reporting System / Pharmacovigilance / Medical device / Pharmaceutical sciences / Pharmacology / Medicine

Webinar on FDA and Drug Safety

Add to Reading List

Source URL: www.fda.gov

Language: English
49WOUR / Medicine / Biology / Health / Food and Drug Administration / Center for Biologics Evaluation and Research / Influenza

WOLLO UNIVERSITY DESSIE CAMPUS OFFICE OF THE REGISTRAR COLLEGE OF BUSINESS AND ECONOMICS COOPERATIVE 2d SEMISTER 2006 E.C 2005 Entry REGULAR LIST NO 1

Add to Reading List

Source URL: www.wu.edu.et

Language: English - Date: 2014-10-07 03:18:53
50Clinical research / Center for Drug Evaluation and Research / Bioequivalence / Center for Biologics Evaluation and Research / Abbreviated New Drug Application / Drug development / Biologic / Biostatistics / Dermatologic and Ophthalmic Drugs Advisory Committee / Food and Drug Administration / Pharmaceutical sciences / Pharmacology

Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA

Add to Reading List

Source URL: www.jpma.or.jp

Language: English - Date: 2015-02-24 20:15:37
UPDATE